559 related articles for article (PubMed ID: 11097960)
1. Familial aggregation of psychotic symptoms in Huntington's disease.
Tsuang D; Almqvist EW; Lipe H; Strgar F; DiGiacomo L; Hoff D; Eugenio C; Hayden MR; Bird TD
Am J Psychiatry; 2000 Dec; 157(12):1955-9. PubMed ID: 11097960
[TBL] [Abstract][Full Text] [Related]
2. [Importance of the number of trinucleotide repeat expansions in the clinical manifestations of Huntington's chorea].
Vojvodić N; Culjković B; Romac S; Stojković O; Sternić N; Sokić D; Kostić VS
Srp Arh Celok Lek; 1998; 126(3-4):77-82. PubMed ID: 9863360
[TBL] [Abstract][Full Text] [Related]
3. A worldwide study of the Huntington's disease mutation. The sensitivity and specificity of measuring CAG repeats.
Kremer B; Goldberg P; Andrew SE; Theilmann J; Telenius H; Zeisler J; Squitieri F; Lin B; Bassett A; Almqvist E
N Engl J Med; 1994 May; 330(20):1401-6. PubMed ID: 8159192
[TBL] [Abstract][Full Text] [Related]
4. Effect of CAG repeat length on psychiatric disorders in Huntington's disease.
Vassos E; Panas M; Kladi A; Vassilopoulos D
J Psychiatr Res; 2008 Jun; 42(7):544-9. PubMed ID: 17610899
[TBL] [Abstract][Full Text] [Related]
5. Familial psychiatric presentation of Huntington's disease.
Lovestone S; Hodgson S; Sham P; Differ AM; Levy R
J Med Genet; 1996 Feb; 33(2):128-31. PubMed ID: 8929949
[TBL] [Abstract][Full Text] [Related]
6. Biological and clinical manifestations of juvenile Huntington's disease: a retrospective analysis.
Fusilli C; Migliore S; Mazza T; Consoli F; De Luca A; Barbagallo G; Ciammola A; Gatto EM; Cesarini M; Etcheverry JL; Parisi V; Al-Oraimi M; Al-Harrasi S; Al-Salmi Q; Marano M; Vonsattel JG; Sabatini U; Landwehrmeyer GB; Squitieri F
Lancet Neurol; 2018 Nov; 17(11):986-993. PubMed ID: 30243861
[TBL] [Abstract][Full Text] [Related]
7. Clinical and genetic characteristics in patients with Huntington's Disease from Argentina.
Gatto E; Parisi V; Persi G; Converso DP; Etcheverry JL; Varela V; Lopez A; Alba L; Fretchel G
Parkinsonism Relat Disord; 2012 Feb; 18(2):166-9. PubMed ID: 21962718
[TBL] [Abstract][Full Text] [Related]
8. [The gene responsible for Huntington's disease in Spanish families: its diagnostic value and the relation between trinucleotide expansion and the clinical characteristics].
Benítez J; Fernández E; García Ruiz P; Robledo M; Ayuso C; García Yébenes J
Rev Clin Esp; 1994 Aug; 194(8):591-3. PubMed ID: 7938836
[TBL] [Abstract][Full Text] [Related]
9. Familial aggregation of schizophrenia-like symptoms in Huntington's disease.
Tsuang D; DiGiacomo L; Lipe H; Bird TD
Am J Med Genet; 1998 Jul; 81(4):323-7. PubMed ID: 9674979
[TBL] [Abstract][Full Text] [Related]
10. [Analysis of trinucleotide repeat expansion as a new mechanism of mutation in Huntington's chorea: theoretical and applied aspects].
Illarioshkin SN; Ivanova-Smolenskaia IA; Markova ED; Nikol'skaia NN; Chabrashvili TZ; Insarova NG
Genetika; 1996 Jan; 32(1):103-9. PubMed ID: 8647411
[TBL] [Abstract][Full Text] [Related]
11. [Huntington chorea: (CAG)n repeats on gene IT 15 in Austria].
Meszaros K; Willinger U; Heiden AM; Fuchs K; Baumhackl U; Brücke T; Feucht M; Fathi N; Lenzinger E; Miller E
Wien Klin Wochenschr; 1994; 106(21):671-2. PubMed ID: 7810152
[TBL] [Abstract][Full Text] [Related]
12. Molecular analysis of the Huntington's disease gene in New Zealand.
Whitefield JE; Williams L; Snow K; Dixon J; Winship I; Stapleton PM; Faull RM; Love DR
N Z Med J; 1996 Feb; 109(1015):27-30. PubMed ID: 8606810
[TBL] [Abstract][Full Text] [Related]
13. Genetic polymorphisms adjacent to the CAG repeat influence clinical features at onset in Huntington's disease.
Vuillaume I; Vermersch P; Destée A; Petit H; Sablonnière B
J Neurol Neurosurg Psychiatry; 1998 Jun; 64(6):758-62. PubMed ID: 9647305
[TBL] [Abstract][Full Text] [Related]
14. Neuropathological diagnosis and CAG repeat expansion in Huntington's disease.
Xuereb JH; MacMillan JC; Snell R; Davies P; Harper PS
J Neurol Neurosurg Psychiatry; 1996 Jan; 60(1):78-81. PubMed ID: 8558157
[TBL] [Abstract][Full Text] [Related]
15. Psychiatric symptoms do not correlate with cognitive decline, motor symptoms, or CAG repeat length in Huntington's disease.
Zappacosta B; Monza D; Meoni C; Austoni L; Soliveri P; Gellera C; Alberti R; Mantero M; Penati G; Caraceni T; Girotti F
Arch Neurol; 1996 Jun; 53(6):493-7. PubMed ID: 8660149
[TBL] [Abstract][Full Text] [Related]
16. Preliminary analysis of Huntington's Disease in South Korea.
Shin CW; Choi YJ; Kim M; Jeon BS
J Huntingtons Dis; 2013; 2(1):83-7. PubMed ID: 25063431
[TBL] [Abstract][Full Text] [Related]
17. Clinical and genetic characteristics in patients with Huntington's disease from China.
Yang J; Chen K; Wei Q; Chen Y; Cao B; Burgunder JM; Shang HF
Neurol Res; 2016 Oct; 38(10):916-20. PubMed ID: 27483361
[TBL] [Abstract][Full Text] [Related]
18. [Huntington's chorea: clinical aspects, genetics and current diagnosis].
Spiegel R
Ther Umsch; 1995 Dec; 52(12):814-20. PubMed ID: 8539653
[TBL] [Abstract][Full Text] [Related]
19. Determinants of Onset of Huntington's Disease with Behavioral Symptoms: Insight from 92 Patients.
Lenka A; Kamble NL; Sowmya V; Jhunjhunwala K; Yadav R; Netravathi M; Kandasamy M; Moily NS; Purushottam M; Jain S; Pal PK
J Huntingtons Dis; 2015; 4(4):319-24. PubMed ID: 26682993
[TBL] [Abstract][Full Text] [Related]
20. Age, CAG repeat length, and clinical progression in Huntington's disease.
Rosenblatt A; Kumar BV; Mo A; Welsh CS; Margolis RL; Ross CA
Mov Disord; 2012 Feb; 27(2):272-6. PubMed ID: 22173986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
